Howard Zisser M.D. is director of clinical research at Sansum Diabetes Research Institute, where he conducts clinical trials on new and innovative therapies for type 1, type 2 and gestational diabetes. He currently manages trials investigating the safety and efficacy of inhaled insulin, of insulin that is absorbed in the cheek, of implantable insulin pumps and implantable glucose sensors.